The Promise and Perils of Psychedelics

In this episode of “Intention to Treat,” some of the people who have worked closely with “America’s Doctor,” Anthony Fauci, offer insights into his character, values, accomplishments, and adventures over his decades of service at the NIH. A full transcript of this episode is avai ...  Show more

In this episode of “Intention to Treat,” Anthony Fauci sits down with host Rachel Gotbaum to discuss his long career in infectious disease and public health, what has motivated him, and the lessons he has learned and taught along the way. A full transcript of this episode is avai ...  Show more

Although psychadelic drugs are largely recreational these days, scientists are looking into potential therapeutic uses -- especially in patients for whom nothing else works. Learn how psilocybin may fight depression in this episode of BrainStuff.

When psychedelics were first studied more than 50 years ago, researchers noticed that they were useful in helping people explore a greater sense of self. Now, after a half-century hiatus, scientists are studying psychedelics like MDMA, psilocybin, and ketamine as treatment for de ...  Show more

Although psychedelic drugs are largely recreational these days, scientists are looking into potential therapeutic uses -- especially in patients for whom nothing else works. Learn how psilocybin may fight depression in this classic episode of BrainStuff. Learn more about your ad- ...  Show more

In this Huberman Lab Essentials episode, my guest is Dr. Matthew Johnson, PhD, a senior researcher for the Center of Excellence for Psilocybin Research and Treatment at Sheppard Pratt’s Institute for Advanced Diagnostics and Therapeutics. We explore the science and therapeutic po ...  Show more